Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity

Zanden, L.F.M. van der; Vermeulen, S.H.; Oskarsdottir, A.; Maurits, J.S.F.; Diekstra, M.H.M.; Ambert, V.; ... ; Oosterwijk, E. (2017)

Article / Letter to editor

• Metastatic renal cell carcinoma
• Therapy response
• Tyrosine kinase inhibitor
• Biomarker
• Transcriptomics
• Genomics

• All authors: Zanden, L.F.M. van der; Vermeulen, S.H.; Oskarsdottir, A.; Maurits, J.S.F.; Diekstra, M.H.M.; Ambert, V.; Cambon-Thomsen, A.; Castellano, D.; Fritsch, A.; Donas, J.G.; Troyas, R.G.; Guchelaar, H.J.; Hartmann, A.; Hulsbergen-van de Kaa, C.; Jaehde, U.; Junker, K.; Martinez-Cardus, A.; Masson, G.; Oosterwijk-Wakka, J.; Radu, M.T.; Rafnar, T.; Rodriguez-Antona, C.; Roessler, M.; Ruijtenbeek, R.; Stefansson, K.; Warren, A.; Wessels, L.; Eisen, T.; Kiemeney, L.A.L.M.; Oosterwijk, E.
• Date: 2017-08-31
• Journal: Urologic Oncology: Seminars and Original Investigations
• Volume: 35
• Issue: 8
• DOI: doi:10.1016/j.urolonc.2017.03.009